Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment

NCT01072812 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision based on funding

Conditions

Alzheimer's Disease
Amnestic Mild Cognitive Impairment

Interventions

DRUG: Posiphen® tartrate capsules

Sponsor

Annovis Bio Inc.